Filter Results:
(700)
Show Results For
- All HBS Web
(700)
- People (2)
- News (118)
- Research (534)
- Events (5)
- Multimedia (1)
- Faculty Publications (295)
Show Results For
- All HBS Web
(700)
- People (2)
- News (118)
- Research (534)
- Events (5)
- Multimedia (1)
- Faculty Publications (295)
- 15 Dec 2003
- Research & Ideas
The New Global Business Manager
constraining, it can move to another one. So while there are few effective transnational governmental bodies, there are very effective transnational corporations. With that power comes a huge responsibility... View Details
Keywords: by Cynthia Churchwell
- 2010
- Article
Estimating the Attributable Cost of Physician Burnout in the United States
By: Shasha Han, Tait D. Shanafelt, Christine A. Sinsky, Karim M. Awad, Liselotte N. Dyrbye, Lynne C. Fiscus, Mickey Trockel and Joel Goh
Background: Although physician burnout is associated with negative clinical and organizational outcomes, its economic costs are poorly understood. As a result, leaders in health care cannot properly assess the financial benefits of initiatives to remediate... View Details
Keywords: Physicians; Burnout; Health; Health Care and Treatment; Employees; Cost; Programs; Policy; Health Industry
Han, Shasha, Tait D. Shanafelt, Christine A. Sinsky, Karim M. Awad, Liselotte N. Dyrbye, Lynne C. Fiscus, Mickey Trockel, and Joel Goh. "Estimating the Attributable Cost of Physician Burnout in the United States." Annals of Internal Medicine 170, no. 11 (June 4, 2019): 784–790.
- 22 Aug 2005
- Research & Ideas
The Hard Work of Failure Analysis
drug could treat osteoporosis and thus developed their one-billion-dollar-a-year drug, Evista, while Strattera, a failed antidepressant, was discovered to be an effective treatment for... View Details
Keywords: by Amy Edmondson & Mark D. Cannon
- 02 Nov 2021
- Research & Ideas
Why COVID-19 Probably Killed More People Than We Realize
for COVID. “When governments ask citizens to make sacrifices,” adds Rouen, “they’re inclined to overstate the positive effects of those sacrifices.” Along the same lines, countries with less stringent policies underreported at a lower... View Details
Keywords: by Michael Blanding
- 12 Jun 2018
- Research & Ideas
In a Landscape of 'Me Too' Drug Development, What Spurs Radical Innovation?
was invented as a treatment for chronic myelogenous leukemia, and by the study’s measures was quite a novel drug. Novartis shares jumped almost 7 percent the day Gleevec was approved by the FDA. The drug proved View Details
- June 2016
- Article
Vaccination Rates Are Associated with Functional Proximity but Not Base Proximity of Vaccination Clinics
By: John Beshears, James J. Choi, David Laibson, Brigitte C. Madrian and Gwendolyn I. Reynolds
Background: Routine annual influenza vaccinations are recommended for persons 6 months of age and older, but less than half of U.S. adults get vaccinated. Many employers offer employees free influenza vaccinations at workplace clinics, but even then take-up is... View Details
Beshears, John, James J. Choi, David Laibson, Brigitte C. Madrian, and Gwendolyn I. Reynolds. "Vaccination Rates Are Associated with Functional Proximity but Not Base Proximity of Vaccination Clinics." Medical Care 54, no. 6 (June 2016): 578–583.
- 2021
- Working Paper
The Health Costs of Cost-Sharing
By: Amitabh Chandra, Evan Flack and Ziad Obermeyer
We use the design of Medicare’s prescription drug benefit program to demonstrate three facts about the health consequences of cost-sharing. First, we show that an as-if-random increase of 33.6% in out-of-pocket price (11.0 percentage points (p.p.) change in... View Details
Chandra, Amitabh, Evan Flack, and Ziad Obermeyer. "The Health Costs of Cost-Sharing." NBER Working Paper Series, No. 28439, February 2021.
- 31 Jul 2019
- Research & Ideas
Distressed Employees? Try Resilience Training
effective solution for companies. She co-wrote the journal article with HBS doctoral student Grace Cormier, as well as three employees of Happify, Allison L. Williams, Acacia C. Parks, and Julia Stafford. Happify, which funded the... View Details
- February 2022
- Case
Leading The UK Vaccine Task Force
By: Amy C. Edmondson and Claudia Pienica
This case describes the first six months of the UK Vaccine Taskforce, under the leadership of Kate Bingham. With a career spent in the private sector as a biotech investor, Bingham’s appointment within the government was considered unusual. The overarching brief given... View Details
Keywords: COVID-19; Vaccine; Government; Health Pandemics; Health Care and Treatment; Science; Innovation and Invention; Groups and Teams; Leadership; Decision Making; Government and Politics; Health; Innovation and Management; Governance; Change; Government Administration; Health Industry; Financial Services Industry; Public Administration Industry; Europe; United Kingdom
Edmondson, Amy C., and Claudia Pienica. "Leading The UK Vaccine Task Force." Harvard Business School Case 622-079, February 2022.
- Profile
Emily Schlichting
At age 19, in the spring of 2009, Emily Schlichting was diagnosed with Behcet's, a rare autoimmune disease that introduced her "to the realities of U.S. health care firsthand." Although the disease has proven manageable, her View Details
- Article
Resilience vs. Vulnerability: Psychological Safety and Reporting of Near Misses with Varying Proximity to Harm in Radiation Oncology
By: Palak Kundu, Olivia Jung, Amy C. Edmondson, Nzhde Agazaryan, John Hegde, Michael Steinberg and Ann Raldow
Background
Psychological safety, a shared belief that interpersonal risk taking is safe, is an important determinant of incident reporting. However, how psychological safety affects near-miss reporting is unclear, as near misses contain contrasting cues that... View Details
Psychological safety, a shared belief that interpersonal risk taking is safe, is an important determinant of incident reporting. However, how psychological safety affects near-miss reporting is unclear, as near misses contain contrasting cues that... View Details
Kundu, Palak, Olivia Jung, Amy C. Edmondson, Nzhde Agazaryan, John Hegde, Michael Steinberg, and Ann Raldow. "Resilience vs. Vulnerability: Psychological Safety and Reporting of Near Misses with Varying Proximity to Harm in Radiation Oncology." Joint Commission Journal on Quality and Patient Safety 47, no. 1 (January 2021): 15–22.
- 19 Dec 2017
- First Look
New Research and Ideas, December 19, 2017
integration into receiving countries. In this study, 23,800 citizens were randomly assigned to receive visits from political activists during the lead-up to the 2010 French regional elections. Treatment increased the turnout of immigrants... View Details
Keywords: Carmen Nobel
- 10 Aug 2015
- Research & Ideas
New Medical Devices Get To Patients Too Slowly
different effects or methods of action, trials essentially consist of monitoring patients for proper dosage, effectiveness, and side effects. Medical devices, meanwhile, can differ from each other in almost every respect, including how... View Details
- 25 Aug 2003
- Research & Ideas
Why IT Does Matter
effectiveness has come the ability to do things truly differently. American Hospital Supply's distribution software and American Airlines' SABRE reservation system are examples of victories in past technologies. The firms were the first... View Details
Keywords: by F. Warren McFarlan & Richard L. Nolan
- 14 Feb 2017
- First Look
First Look at New Research: February 14
countries. I find that price levels are identical about 72% of the time. Price changes are not synchronized but have similar frequencies and average sizes. These results have implications for national statistical offices, researchers using online data, and anyone... View Details
Keywords: Sean Silverthorne
- 2009
- Working Paper
Broadening Focus: Spillovers, Complementarities and Specialization in the Hospital Industry
By: Jonathan R. Clark and Robert S. Huckman
The long-standing argument that focused operations outperform others stands in contrast to claims about the benefits of broader operational scope. The performance benefits of focus are typically attributed to reduced complexity, lower uncertainty, and the development... View Details
Keywords: Health Care and Treatment; Medical Specialties; Performance Capacity; Diversification; Health Industry
Clark, Jonathan R., and Robert S. Huckman. "Broadening Focus: Spillovers, Complementarities and Specialization in the Hospital Industry." Harvard Business School Working Paper, No. 09-120, April 2009. (Revised April 2011.)
- Web
Technology & Operations Management Awards & Honors - Faculty & Research
Management Division (STR) of the Academy of Management with Cirrus Foroughi and Barbara Larson for "Work-from-anywhere: The Productivity Effects of Geographic Flexibility." Prithwiraj Choudhury : Finalist for the 2020 HBR McKinsey Award... View Details
- 27 Sep 2011
- First Look
First Look: September 27
(forthcoming) An abstract is unavailable at this time. The Variance of Non-Parametric Treatment Effect Estimators in the Presence of Clustering Authors:Samuel G. Hanson and Adi Sunderam Publication:The... View Details
Keywords: Sean Silverthorne
- September 2016
- Article
Value Based Care and Bundled Payments: Anesthesia Care Costs for Outpatient Oncology Surgery Using Time-driven Activity-based Costing
By: Katy E. French, Alexis B. Guzman, Augustin C. Rubio, John C. Frenzel and Thomas Feeley
Background:
With the movement towards bundled payments, stakeholders should know the true cost of the care they deliver. Time-driven activity-based costing (TDABC) can be used to estimate costs for each episode of care. In this analysis, TDABC is used to both... View Details
French, Katy E., Alexis B. Guzman, Augustin C. Rubio, John C. Frenzel, and Thomas Feeley. "Value Based Care and Bundled Payments: Anesthesia Care Costs for Outpatient Oncology Surgery Using Time-driven Activity-based Costing." Healthcare: The Journal of Delivery Science and Innovation 4, no. 3 (September 2016): 173–180.
- 06 Nov 2012
- First Look
First Look: November 6
is related to higher UK CEO pay; however, the effect is similar when UK firms have a listing in any foreign country implying a foreign listing effect not unique to the U.S. Product market relationships... View Details
Keywords: Sean Silverthorne